Evolving treatment paradigms in hemophilia: A written recap
In this Managed Healthcare Executive K-Cast video series, Annette von Drygalski, M.D., Pharm.D., discussed the evolution of hemophilia care from...
hemophilia
Long-acting therapies reshape hemophilia care beyond bleeding prevention < Hospital < Article
Treatment for hemophilia A is no longer limited to responding to bleeding episodes as they occur. To...
Evolving treatment paradigms in hemophilia: Written recap
In this Managed Healthcare Executive K-Cast video series, Annette von Drygalski, M.D., Pharm.D., discussed the evolution of hemophilia care from...
For hemophilia patients, January brings out-of-pocket maximum woes
Out-of-pocket maximum: This term is used by health insurance companies to inform customers of the maximum amount they may have...
New FVIII Mutation Offers Insights for Future Hemophilia A Treatments
Researchers have found a previously unknown mutation in the factor VIII (FVIII) gene that accelerates blood clotting. This discovery could...
Antihemophilic Factor Market, Transforming Hemophilia Care
Antihemophilic Factor MarketOverview of the Antihemophilic Factor MarketThe global Antihemophilic Factor (AHF) market is experiencing robust growth, driven by rising...
